Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

TherapeuticsMD Inc (TXMD) USD0.10

Sell:$2.29 Buy:$2.35 Change: $0.07 (2.95%)
NASDAQ:0.20%
Market closed |  Prices as at close on 13 December 2019 | Switch to live prices |
Sell:$2.29
Buy:$2.35
Change: $0.07 (2.95%)
Market closed |  Prices as at close on 13 December 2019 | Switch to live prices |
Sell:$2.29
Buy:$2.35
Change: $0.07 (2.95%)
Market closed |  Prices as at close on 13 December 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials are designed to alleviate symptoms of and reduce health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis and vaginal discomfort. With its SYMBODA technology, it is developing hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through dosage forms and administration routes. Its product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.

Contact details

Address:
951 W Yamato Rd Ste 220
BOCA RATON
33431-4440
United States
Telephone:
+1 (561) 9611900
Website:
https://www.therapeuticsmd.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
TXMD
ISIN:
US88338N1072
Market cap:
$642.69 million
Shares in issue:
271.18 million
Sector:
Pharmaceuticals
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Tommy Thompson
    Independent Chairman of the Board
  • John Milligan
    President, Secretary and Director
  • Robert Finizio
    Chief Executive Officer and Director
  • Brian Bernick
    Co-Founder and Director
  • Daniel Cartwright
    Chief Financial Officer and Treasurer
  • Michael Donegan
    Vice President - Finance
  • Mitchell Krassan
    Chief Strategy and Performance Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.